The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Small Volume Parenterals (SVP) Market Research Report 2025
Synopsis
Small volume parenteral (SVP) solutions are usually 100 ml or less and are packaged in different ways depending on the intended use. If the SVP is a liquid that is used primarily to deliver medications, it is packaged in a small plastic bag called a minibag of 50 - 100 ml (minibags look like small plastic LVP bags). SVPs can also be packaged as ampules, vials, and prefilled syringes. Liquid drugs are supplied in prefilled syringes, heat-sealed ampules, or in vials sealed with a rubber closure. Powdered drugs are supplied in vials and must be constituted (dissolved in a suitable liquid) before being added to any solution. SVPs packaged as ampules, vials, or prefilled syringes are typically added to a minibag or a LVP but they may also serve as the final container. The term admixture is used to denote a solution where such an additive has been added to a minibag or LVP.
The global Small Volume Parenterals (SVP) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Small Volume Parenterals (SVP) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Volume Parenterals (SVP) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Small Volume Parenterals (SVP) include Allergan, Bayer, GSK, J&J, Pfizer, Teva and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Volume Parenterals (SVP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Volume Parenterals (SVP).
Report Scope
The Small Volume Parenterals (SVP) market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Volume Parenterals (SVP) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Volume Parenterals (SVP) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Bayer
GSK
J&J
Pfizer
Teva
Novartis
Segment by Type
Ampules
Vials
Prefilled Syringes
Segment by Application
Local Anesthetics
Vaccines
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Small Volume Parenterals (SVP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Small Volume Parenterals (SVP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Small volume parenteral (SVP) solutions are usually 100 ml or less and are packaged in different ways depending on the intended use. If the SVP is a liquid that is used primarily to deliver medications, it is packaged in a small plastic bag called a minibag of 50 - 100 ml (minibags look like small plastic LVP bags). SVPs can also be packaged as ampules, vials, and prefilled syringes. Liquid drugs are supplied in prefilled syringes, heat-sealed ampules, or in vials sealed with a rubber closure. Powdered drugs are supplied in vials and must be constituted (dissolved in a suitable liquid) before being added to any solution. SVPs packaged as ampules, vials, or prefilled syringes are typically added to a minibag or a LVP but they may also serve as the final container. The term admixture is used to denote a solution where such an additive has been added to a minibag or LVP.
The global Small Volume Parenterals (SVP) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Small Volume Parenterals (SVP) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Volume Parenterals (SVP) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Small Volume Parenterals (SVP) include Allergan, Bayer, GSK, J&J, Pfizer, Teva and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Volume Parenterals (SVP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Volume Parenterals (SVP).
Report Scope
The Small Volume Parenterals (SVP) market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Volume Parenterals (SVP) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Volume Parenterals (SVP) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Bayer
GSK
J&J
Pfizer
Teva
Novartis
Segment by Type
Ampules
Vials
Prefilled Syringes
Segment by Application
Local Anesthetics
Vaccines
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Small Volume Parenterals (SVP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Small Volume Parenterals (SVP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Small Volume Parenterals (SVP) Market Overview
1.1 Product Overview and Scope of Small Volume Parenterals (SVP)
1.2 Small Volume Parenterals (SVP) Segment by Type
1.2.1 Global Small Volume Parenterals (SVP) Market Value Comparison by Type (2024-2030)
1.2.2 Ampules
1.2.3 Vials
1.2.4 Prefilled Syringes
1.3 Small Volume Parenterals (SVP) Segment by Application
1.3.1 Global Small Volume Parenterals (SVP) Market Value by Application: (2024-2030)
1.3.2 Local Anesthetics
1.3.3 Vaccines
1.3.4 Other
1.4 Global Small Volume Parenterals (SVP) Market Size Estimates and Forecasts
1.4.1 Global Small Volume Parenterals (SVP) Revenue 2019-2030
1.4.2 Global Small Volume Parenterals (SVP) Sales 2019-2030
1.4.3 Global Small Volume Parenterals (SVP) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Small Volume Parenterals (SVP) Market Competition by Manufacturers
2.1 Global Small Volume Parenterals (SVP) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Small Volume Parenterals (SVP) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Small Volume Parenterals (SVP) Average Price by Manufacturers (2019-2024)
2.4 Global Small Volume Parenterals (SVP) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Small Volume Parenterals (SVP), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Small Volume Parenterals (SVP), Product Type & Application
2.7 Small Volume Parenterals (SVP) Market Competitive Situation and Trends
2.7.1 Small Volume Parenterals (SVP) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Small Volume Parenterals (SVP) Players Market Share by Revenue
2.7.3 Global Small Volume Parenterals (SVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Small Volume Parenterals (SVP) Retrospective Market Scenario by Region
3.1 Global Small Volume Parenterals (SVP) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Small Volume Parenterals (SVP) Global Small Volume Parenterals (SVP) Sales by Region: 2019-2030
3.2.1 Global Small Volume Parenterals (SVP) Sales by Region: 2019-2024
3.2.2 Global Small Volume Parenterals (SVP) Sales by Region: 2025-2030
3.3 Global Small Volume Parenterals (SVP) Global Small Volume Parenterals (SVP) Revenue by Region: 2019-2030
3.3.1 Global Small Volume Parenterals (SVP) Revenue by Region: 2019-2024
3.3.2 Global Small Volume Parenterals (SVP) Revenue by Region: 2025-2030
3.4 North America Small Volume Parenterals (SVP) Market Facts & Figures by Country
3.4.1 North America Small Volume Parenterals (SVP) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Small Volume Parenterals (SVP) Sales by Country (2019-2030)
3.4.3 North America Small Volume Parenterals (SVP) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Small Volume Parenterals (SVP) Market Facts & Figures by Country
3.5.1 Europe Small Volume Parenterals (SVP) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Small Volume Parenterals (SVP) Sales by Country (2019-2030)
3.5.3 Europe Small Volume Parenterals (SVP) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Small Volume Parenterals (SVP) Market Facts & Figures by Country
3.6.1 Asia Pacific Small Volume Parenterals (SVP) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Small Volume Parenterals (SVP) Sales by Country (2019-2030)
3.6.3 Asia Pacific Small Volume Parenterals (SVP) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Small Volume Parenterals (SVP) Market Facts & Figures by Country
3.7.1 Latin America Small Volume Parenterals (SVP) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Small Volume Parenterals (SVP) Sales by Country (2019-2030)
3.7.3 Latin America Small Volume Parenterals (SVP) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Small Volume Parenterals (SVP) Market Facts & Figures by Country
3.8.1 Middle East and Africa Small Volume Parenterals (SVP) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Small Volume Parenterals (SVP) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Small Volume Parenterals (SVP) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Small Volume Parenterals (SVP) Sales by Type (2019-2030)
4.1.1 Global Small Volume Parenterals (SVP) Sales by Type (2019-2024)
4.1.2 Global Small Volume Parenterals (SVP) Sales by Type (2025-2030)
4.1.3 Global Small Volume Parenterals (SVP) Sales Market Share by Type (2019-2030)
4.2 Global Small Volume Parenterals (SVP) Revenue by Type (2019-2030)
4.2.1 Global Small Volume Parenterals (SVP) Revenue by Type (2019-2024)
4.2.2 Global Small Volume Parenterals (SVP) Revenue by Type (2025-2030)
4.2.3 Global Small Volume Parenterals (SVP) Revenue Market Share by Type (2019-2030)
4.3 Global Small Volume Parenterals (SVP) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Small Volume Parenterals (SVP) Sales by Application (2019-2030)
5.1.1 Global Small Volume Parenterals (SVP) Sales by Application (2019-2024)
5.1.2 Global Small Volume Parenterals (SVP) Sales by Application (2025-2030)
5.1.3 Global Small Volume Parenterals (SVP) Sales Market Share by Application (2019-2030)
5.2 Global Small Volume Parenterals (SVP) Revenue by Application (2019-2030)
5.2.1 Global Small Volume Parenterals (SVP) Revenue by Application (2019-2024)
5.2.2 Global Small Volume Parenterals (SVP) Revenue by Application (2025-2030)
5.2.3 Global Small Volume Parenterals (SVP) Revenue Market Share by Application (2019-2030)
5.3 Global Small Volume Parenterals (SVP) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Small Volume Parenterals (SVP) Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Small Volume Parenterals (SVP) Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Small Volume Parenterals (SVP) Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 J&J
6.4.1 J&J Corporation Information
6.4.2 J&J Description and Business Overview
6.4.3 J&J Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 J&J Small Volume Parenterals (SVP) Product Portfolio
6.4.5 J&J Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Small Volume Parenterals (SVP) Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Small Volume Parenterals (SVP) Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Small Volume Parenterals (SVP) Product Portfolio
6.7.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Small Volume Parenterals (SVP) Industry Chain Analysis
7.2 Small Volume Parenterals (SVP) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Small Volume Parenterals (SVP) Production Mode & Process
7.4 Small Volume Parenterals (SVP) Sales and Marketing
7.4.1 Small Volume Parenterals (SVP) Sales Channels
7.4.2 Small Volume Parenterals (SVP) Distributors
7.5 Small Volume Parenterals (SVP) Customers
8 Small Volume Parenterals (SVP) Market Dynamics
8.1 Small Volume Parenterals (SVP) Industry Trends
8.2 Small Volume Parenterals (SVP) Market Drivers
8.3 Small Volume Parenterals (SVP) Market Challenges
8.4 Small Volume Parenterals (SVP) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
